Dr. Yoon-Jae Y Cho, MD is a Neurologist - Special Qualifications in Child Neurology practicing in Palo Alto, CA
He has not yet shared a personalized biography with Doctor.com.
Institution | Focus | Year |
---|---|---|
Internship - Children's Hospital of Pittsburgh, Pittsburgh PA (2003) | Not Specified | |
Internship - Children's Hospital of Pittsburgh PA (2003) | Not Specified | |
Fellowship - Children's Hospital Boston, Boston MA | 2008 | |
Fellowship - Children's Hospital Boston MA | 2008 |
Certification | Cert. Body | Year |
---|---|---|
Neurology with Special Qualification in Child Neurology | Psychiatry and Neurology | 2009 |
Distinction | Institution | Year |
---|---|---|
Faculty Development Award, Shore Fellowship Program for Scholars in Me | 2009-2011 | |
Young Investigator Award, Pediatric Brain Tumor Foundation | 2007 | |
Laurel MD-PhD Scholar, Oregon Medical Research Foundation | 1994-2002 | |
Biology Committee, Pediatric Brain Tumor Consortium | 2012 | |
Philip R. Dodge Young Investigator Award, Child Neurology Society | 2012 | |
Beirne Faculty Scholar in Pediatirc Neuro-oncology, Stanford Universi | 2011 | |
Scholar, St. Baldrick's Foundation | 2011 |
Publication | Publisher | Title | Published |
---|---|---|---|
Other Publication | ture medicine | Epigenetic targeting of Hedgehog pathway transcriptiol output through BET bromodomain inhibition. | 2014 |
Other Publication | Cancer cell | Reduced H3K27me3 and D Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant | 2013 |
Other Publication | TURE | Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations | 2012 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Integrative Genomic Alysis of Medullobl | 2011 |
Other Publication | ACTA NEUROPATHOLOGICA | alpha 5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth | 2014 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Cytogenetic Prognostication Within Medulloblastoma Subgroups | 2014 |
Other Publication | CANCER CELL | Genome Sequencing of SHH Medulloblastoma Predicts Genotype | 2014 |
Other Publication | Jourl of neuro-oncology | Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct | 2014 |
Other Publication | Clinical cancer research | BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma. | 2014 |
Other Publication | ACTA NEUROPATHOLOGICA | Medulloblastoma Down Under 2013 | 2014 |
Other Publication | Acta neuropathologica | TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. | 2013 |
Other Publication | lancet oncology | Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular alysis. | 2013 |
Other Publication | Jourl of clinical oncology | Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma. | 2013 |
Other Publication | ture genetics | Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. | 2013 |
Other Publication | ture | BAF complexes facilitate decatetion of D by topoisomerase IIa. | 2013 |
Other Publication | Proceedings of the tiol Academy of Sciences of the United States of Am | Genomic alysis of diffuse pediatric low | 2013 |
Other Publication | MOLECULAR CANCER RESEARCH | Inhibition of TWIST1 Leads to Activation of Oncogene-Induced Senescence in Oncogene | 2013 |
Other Publication | MOLECULAR CANCER | Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 sigling | 2013 |
Other Publication | Oncogene | Activation of ?-catenin/TCF targets following loss of the tumor suppressor SNF5. | |
Other Publication | COLD SPRING HARBOR PERSPECTIVES IN MEDICINE | The VEGF Pathway in Cancer and Disease: Responses, Resistance, and the Path Forward | 2012 |
Other Publication | TURE REVIEWS CANCER | Medulloblastomics: the end of the beginning | 2012 |
Other Publication | TURE | Subgroup-specific structural variation across 1,000 medulloblastoma genomes | 2012 |
Other Publication | TURE | Dissecting the genomic complexity underlying medulloblastoma | 2012 |
Other Publication | CELL CYCLE | Epigenetic ictivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors | 2012 |
Other Publication | PLOS GENETICS | Twist1 Suppresses Senescence Programs and Thereby Accelerates and Maintains Mutant Kras | 2012 |
Other Publication | ACTA NEUROPATHOLOGICA | Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples | 2012 |
Other Publication | ACTA NEUROPATHOLOGICA | Molecular subgroups of medulloblastoma | 2012 |
Other Publication | ACTA NEUROPATHOLOGICA | MicroR-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma | 2012 |
Other Publication | ACTA NEUROPATHOLOGICA | Pleiotropic effects of miR-183 similar to 96 similar to 182 converge to regulate cell survival | 2012 |
Other Publication | ACTA NEUROPATHOLOGICA | Molecular subgroups of medulloblastoma: the current consensus | 2012 |
Other Publication | ACTA NEUROPATHOLOGICA | Biological and clinical heterogeneity of MYCN-amplified medulloblastoma | 2012 |
Other Publication | TURE | Clol selection drives genetic divergence of metastatic medulloblastoma | 2012 |
Other Publication | CANCER CELL | An Animal Model of MYC-Driven Medulloblastoma | 2012 |
Other Publication | Clinical cancer research | Expression of FoxM1 is required for the proliferation of medulloblastoma cells | 2011 |
Other Publication | CANCER CELL | Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma | 2011 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Predicting Relapse in Patients With Medulloblastoma by Integrating Evidence From Clinical | 2011 |
Other Publication | FUTURE ONCOLOGY | Molecular fingerprints of medulloblastoma and their application to clinical practice | 2011 |
Other Publication | NEURO-ONCOLOGY | miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma | 2011 |
Other Publication | TURE COMMUNICATIONS | Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences | 2011 |
Other Publication | TURE MEDICINE | Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway | 2010 |
Other Publication | NEURO-ONCOLOGY | Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma | 2010 |
Other Publication | CANCER CELL | Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation | 2010 |
Other Publication | TURE | The landscape of somatic copy-number alteration across human cancers | 2010 |
Other Publication | NEUROLOGY | MELATONIN DEFICIENCY AND DISRUPTED CIRCADIAN RHYTHMS IN PEDIATRIC SURVIVORS OF CRANIOPHARYNGIOMA | 2009 |
Other Publication | MOLECULAR AND CELLULAR BIOLOGY | Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability | 2008 |
Dr. Yoon-Jae Y Cho, MD has not yet indicated the hospitals that he is affiliated with.
Years In Practice: 16 (started in 2009)
Accepts New Patients: Yes